ESC TV Today – Your Cardiovascular News cover image

Season 2 - ESC TV Today 2023 Year-end Edition

ESC TV Today – Your Cardiovascular News

00:00

Treatment of Subclinical Atrial Fibrillation: Balancing Stroke Risk and Bleeding

In this chapter, the hosts discuss the Atesia trial which compares oral anticoagulant therapy with apixaban or rivaroxaban to aspirin in patients with subclinical atrial fibrillation. The study finds that while apixaban reduces the risk of stroke, it also increases the risk of GI bleeding, highlighting the need to carefully consider the risks and benefits of treatment.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app